Literature DB >> 11842102

Analysis of the structure of human telomerase RNA in vivo.

Mária Antal1, Eva Boros, Ferenc Solymosy, Tamás Kiss.   

Abstract

Telomerase is a ribonucleoprotein reverse transcriptase that synthesises telomeric DNA. The RNA component of telomerase acts as a template for telomere synthesis and binds the reverse transcriptase. In this study, we have performed in vivo and in vitro structural analyses of human telomerase RNA (hTR). In vivo mapping experiments showed that the 5'-terminal template domain of hTR folds into a long hairpin structure, in which the template sequence occupies a readily accessible position. Intriguingly, neither in vivo nor in vitro mapping of hTR confirmed formation of a stable 'pseudoknot' helix, suggesting that this functionally essential long range interaction is formed only temporarily. In vitro control mappings demonstrated that the 5'-terminal template domain of hTR cannot fold correctly in the absence of cellular protein factors. The 3'-terminal domain of hTR, both in vivo and in vitro, folds into the previously predicted box H/ACA snoRNA-like 'hairpin-hinge-hairpin-tail' structure. Finally, comparison of the in vivo and in vitro modification patterns of hTR revealed several regions that might be directly involved in binding of telomerase reverse transcriptase or other telomerase proteins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11842102      PMCID: PMC100349          DOI: 10.1093/nar/30.4.912

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  44 in total

1.  A telomerase component is defective in the human disease dyskeratosis congenita.

Authors:  J R Mitchell; E Wood; K Collins
Journal:  Nature       Date:  1999-12-02       Impact factor: 49.962

2.  A small nucleolar guide RNA functions both in 2'-O-ribose methylation and pseudouridylation of the U5 spliceosomal RNA.

Authors:  B E Jády; T Kiss
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

3.  Secondary structure of vertebrate telomerase RNA.

Authors:  J L Chen; M A Blasco; C W Greider
Journal:  Cell       Date:  2000-03-03       Impact factor: 41.582

Review 4.  Small nucleolar RNA-guided post-transcriptional modification of cellular RNAs.

Authors:  T Kiss
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

5.  The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein.

Authors:  D Gilley; E H Blackburn
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-08       Impact factor: 11.205

6.  Functional regions of human telomerase reverse transcriptase and human telomerase RNA required for telomerase activity and RNA-protein interactions.

Authors:  F Bachand; C Autexier
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

7.  Identification of functional domains and dominant negative mutations in vertebrate telomerase RNA using an in vivo reconstitution system.

Authors:  L Martin-Rivera; M A Blasco
Journal:  J Biol Chem       Date:  2000-10-30       Impact factor: 5.157

8.  Human telomerase activation requires two independent interactions between telomerase RNA and telomerase reverse transcriptase.

Authors:  J R Mitchell; K Collins
Journal:  Mol Cell       Date:  2000-08       Impact factor: 17.970

9.  Human H/ACA small nucleolar RNPs and telomerase share evolutionarily conserved proteins NHP2 and NOP10.

Authors:  V Pogacić; F Dragon; W Filipowicz
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

10.  In vitro assembly of human H/ACA small nucleolar RNPs reveals unique features of U17 and telomerase RNAs.

Authors:  F Dragon; V Pogacić; W Filipowicz
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

View more
  43 in total

1.  The solution structure of an essential stem-loop of human telomerase RNA.

Authors:  Thomas Leeper; Nicolas Leulliot; Gabriele Varani
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

2.  A role for a novel 'trans-pseudoknot' RNA-RNA interaction in the functional dimerization of human telomerase.

Authors:  Hinh Ly; Lifeng Xu; Melissa A Rivera; Tristram G Parslow; Elizabeth H Blackburn
Journal:  Genes Dev       Date:  2003-05-01       Impact factor: 11.361

3.  A domain-based model for predicting large and complex pseudoknotted structures.

Authors:  Song Cao; Shi-Jie Chen
Journal:  RNA Biol       Date:  2012-02-01       Impact factor: 4.652

4.  Structurally conserved five nucleotide bulge determines the overall topology of the core domain of human telomerase RNA.

Authors:  Qi Zhang; Nak-Kyoon Kim; Robert D Peterson; Zhonghua Wang; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-21       Impact factor: 11.205

5.  The 5' guanosine tracts of human telomerase RNA are recognized by the G-quadruplex binding domain of the RNA helicase DHX36 and function to increase RNA accumulation.

Authors:  Alec N Sexton; Kathleen Collins
Journal:  Mol Cell Biol       Date:  2010-12-13       Impact factor: 4.272

6.  Telomerase limits the extent of base pairing between template RNA and telomeric DNA.

Authors:  Klaus Förstemann; Joachim Lingner
Journal:  EMBO Rep       Date:  2005-04       Impact factor: 8.807

7.  Analysis of a long-range interaction between conserved domains of human telomerase RNA.

Authors:  Christine T Ueda; Richard W Roberts
Journal:  RNA       Date:  2004-01       Impact factor: 4.942

8.  Comprehensive structure-function analysis of the core domain of human telomerase RNA.

Authors:  Hinh Ly; Elizabeth H Blackburn; Tristram G Parslow
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Functional organization of repeat addition processivity and DNA synthesis determinants in the human telomerase multimer.

Authors:  Tara J Moriarty; Delphine T Marie-Egyptienne; Chantal Autexier
Journal:  Mol Cell Biol       Date:  2004-05       Impact factor: 4.272

10.  A novel pseudoknot element is essential for the action of a yeast telomerase.

Authors:  Yehuda Tzfati; Zachary Knight; Jagoree Roy; Elizabeth H Blackburn
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.